Versant Capital Management’s Vaxcyte PCVX Stock Holding History

Versant Capital Management’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$15.4K	Sell
2025 Q2	$65.5K	Buy
2025 Q1	$6.16K	Buy
2024 Q4	$7.53K	Buy
2024 Q3	$2.06K	Buy
2023 Q3	–	Sell
2023 Q2	$449	Buy